Skip to main content
Home
Home
  • Register here
  • Sign In
  • Home
  • News Feed
  • Therapeutic areas
    • Cardio-Metabolic
      • Heart Failures
      • Dyslipidemia
    • Dermatology
      • Psoriasis (PsO)
    • Rheumatology
      • Spondyloarthritis
    • Ophthalmology
      • Ophthalmology
    • Respiratory
      • BLOCK IgE; UNLOCK LIFE in 3 indications
      • IgE-Related Chronic Diseases
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Melanoma
      • Oncology Publication
    • Hematology
      • CML
      • ITP
      • MPN
      • SAA
    • Transplant
      • Transplant
    • Neurology
      • Dementia
    • Rare Disease
      • Spinal Muscular Atrophy (SMA)
  • Exclusive event
  • Pharma Corner

Popular Search

  • heart
  • heart failure
  • medical
  • medical information/c
  • dme

Recent News

IgE-Related Chronic Diseases TISTOK
LIPID Management and CVD Forum 2024
PEAK 2024 (SAA & MPN)
Search
  1. VDO test

https://www.kaltura.com/index.php/extwidget/preview/partner_id/2076321/uiconf_id/46737343/entry_id/1_5xrpv9k9/embed/iframe?

×

Medical Information Request

×

Ask Speakers

Latest Content

Breast Cancer

Print

LET hER 5MILE the series EP.8 Efficacy and Safety of CDK4/6i in clinical practice

Prescribing Rights: 
HCP
HCP Rx
Rating: 
Average: 1.5 (92 votes)
NP4 -: 
439636
Print
Dyslipidemia Webinar

Dyslipidemia Webinar

Upcoming Event //--> 01 min 52 sec INCLISIRAN: The First and Only siRNA in LDL-C lowering therapy //--> 09 min 27 sec CV Prevention Hero Ep.2

Show More

Print
Oncology Rerun Webinar

Oncology Rerun Webinar

New Release SOS: Solid Evidence of Breast Cancer Year In ReviewShow More
Print

LET hER 5MILE the series EP.7 Young Women and Advanced Breast Cancer.

Prescribing Rights: 
HCP
HCP Rx
Rating: 
Average: 1.4 (50 votes)
NP4 -: 
439636
Print
Dyslipidemia Guidelines

Dyslipidemia Guidelines

2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA Guideline on the Management of Blood Cholesterol

Chairs: Grundy SM, Stone NJ, et al. Nov-2018 DOI: 10.1161/CIR.0000000000000625

Checkout

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduceShow More
Print
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
 of  38
Sitemap
©2025 Novartis Pharma
  • Terms of use
  • Privacy
The site is intended for HCP local audiences